Bodour Salhia

University of Southern California — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

34h-index5.1kcitations327works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(94), Epigenetics and DNA Methylation(65), RNA modifications and cancer(43), Chemical Reactions and Isotopes(34), Brain Metastases and Treatment(33)

Publications327 total

Supplementary Figure S2 from ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS Metastasis
2025Open Access
Supplementary Figure S1 from ATM-Inhibitor AZD1390 Is a Radiosensitizer for Breast Cancer CNS Metastasis
2025Open Access
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors
Nature Communications·2025· 3 citedOpen Access
Abstract A039: Colorectal cancer in Hispanic and Latino populations: Genetic similarity and molecular drivers identified via multi-omics analysis
Cancer Epidemiology Biomarkers & Prevention·2025
Germline <i>POT1</i> Variants in a Pan-Cancer Cohort
JCO Precision Oncology·2025· 1 cited
Abstract P4-05-26: MamaTrace - A cell-free DNA methylation plasma only assay for minimal residual disease detection in breast cancer
Clinical Cancer Research·2025
MammaTrace – a cell-free DNA methylation plasma only assay for minimal residual disease detection in breast cancer patients
2025Open Access
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes
Nature Communications·2025· 5 citedOpen Access
Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer Recurrence
JCO Precision Oncology·2025· 2 citedOpen Access
Abstract 1128: Comprehensive multi-omics analysis of colorectal cancer tumors in diverse populations
Cancer Research·2025· 1 cited
Abstract 4026: The Bench with Bedside Initiative™: an unconventional collaborative approach between scientists and research participants
Cancer Research·2025
Abstract 45: PDX technology transfer: NCI cancer center to HBCU
Cancer Research·2025
Supplemental Figure S1 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
2025Open Access
Supplemental Figure S2 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
2025Open Access
Supplemental Figure S6 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
2025Open Access
Supplemental Table S1 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
2025Open Access
Supplemental Figure S7 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
2025Open Access
Supplemental Figure S5 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
2025Open Access
Supplemental Figure S9 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
2025Open Access
Supplemental Figure S4 from The EP3–ZNF488 Axis Promotes Self-Renewal of Glioma Stem-Like Cells to Induce Resistance to Tumor Treating Fields
2025Open Access
page 1 of 17Next →

Frequent Co-authors

James T. Rutka(11), John D. Carpten(9), Gerald Gooden(7), Nhan L. Tran(6), Christophe Legendre(6), Ben Yi Tew(6), Michael E. Berens(5), Jeffrey Kiefer(4), Coya Tapia(4), Timothy J. Triche(3), Rae Anne Martinez(3), Kyle N. Johnson(3), Sungwon Jung(3), Angela Baker(3), David W. Craig(3), Mitsutoshi Nakada(3), Marc Symons(3), Min Yu(3), Christian A. Smith(3), Nikola Čihorić(3)